Nasimah Maricar1,2, Michael J Callaghan3,4, Matthew J Parkes3,4, David T Felson3,4, Terence W O'Neill3,4. 1. From the Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, Manchester Academic Health Science Centre (MAHSC), University of Manchester; UK National Institute for Health Research (NIHR) Manchester Musculoskeletal Biomedical Research Unit, Central Manchester National Health Service (NHS) Foundation Trust, MAHSC, Manchester; Department of Physiotherapy, and Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA. nasimah.maricar@postgrad.manchester.ac.uk nasimah.maricar@srft.nhs.uk. 2. N. Maricar, BSc (Hons), MSc, PhD, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC, and Department of Physiotherapy, Salford Royal NHS Foundation Trust; M.J. Callaghan, PhD, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC; M.J. Parkes, BSc (Hons), Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC; D.T. Felson, MD, MPH, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC, and Clinical Epidemiology Unit, Boston University School of Medicine; T.W. O'Neill, MB, BCh, BAO, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC, and Department of Rheumatology, Salford Royal NHS Foundation Trust. nasimah.maricar@postgrad.manchester.ac.uk nasimah.maricar@srft.nhs.uk. 3. From the Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, Manchester Academic Health Science Centre (MAHSC), University of Manchester; UK National Institute for Health Research (NIHR) Manchester Musculoskeletal Biomedical Research Unit, Central Manchester National Health Service (NHS) Foundation Trust, MAHSC, Manchester; Department of Physiotherapy, and Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA. 4. N. Maricar, BSc (Hons), MSc, PhD, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC, and Department of Physiotherapy, Salford Royal NHS Foundation Trust; M.J. Callaghan, PhD, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC; M.J. Parkes, BSc (Hons), Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC; D.T. Felson, MD, MPH, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC, and Clinical Epidemiology Unit, Boston University School of Medicine; T.W. O'Neill, MB, BCh, BAO, Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, MAHSC, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, MAHSC, and Department of Rheumatology, Salford Royal NHS Foundation Trust.
Abstract
OBJECTIVE: Clinical examination of the knee is subject to measurement error. The aim of this analysis was to determine interobserver and intraobserver reliability of commonly used clinical tests in patients with knee osteoarthritis (OA). METHODS: We studied subjects with symptomatic knee OA who were participants in an open-label clinical trial of intraarticular steroid therapy. Following standardization of the clinical test procedures, 2 clinicians assessed 25 subjects independently at the same visit, and the same clinician assessed 88 subjects over an interval period of 2-10 weeks; in both cases prior to the steroid intervention. Clinical examination included assessment of bony enlargement, crepitus, quadriceps wasting, knee effusion, joint-line and anserine tenderness, and knee range of movement (ROM). Intraclass correlation coefficients (ICC), estimated kappa (κ), weighted kappa (κω), and Bland-Altman plots were used to determine interobserver and intraobserver levels of agreement. RESULTS: Using Landis and Koch criteria, interobserver κ scores were moderate for patellofemoral joint (κ = 0.53) and anserine tenderness (κ = 0.48); good for bony enlargement (κ = 0.66), quadriceps wasting (κ = 0.78), crepitus (κ = 0.78), medial tibiofemoral joint tenderness (κ = 0.76), and effusion assessed by ballottement (κ = 0.73) and bulge sign (κω = 0.78); and excellent for lateral tibiofemoral joint tenderness (κ = 1.00), flexion (ICC = 0.97), and extension (ICC = 0.87) ROM. Intraobserver κ scores were moderate for lateral tibiofemoral joint tenderness (κ = 0.60); good for crepitus (κ = 0.78), effusion assessed by ballottement test (κ = 0.77), patellofemoral joint (κ = 0.66), medial tibiofemoral joint (κ = 0.64), and anserine tenderness (κ = 0.73); and excellent for effusion assessed by bulge sign (κω = 0.83), bony enlargement (κ = 0.98), quadriceps wasting (κ = 0.83), flexion (ICC = 0.99), and extension (ICC = 0.96) ROM. CONCLUSION: Among individuals with symptomatic knee OA, the reliability of clinical examination of the knee was at least good for the majority of clinical signs of knee OA.
OBJECTIVE: Clinical examination of the knee is subject to measurement error. The aim of this analysis was to determine interobserver and intraobserver reliability of commonly used clinical tests in patients with knee osteoarthritis (OA). METHODS: We studied subjects with symptomatic knee OA who were participants in an open-label clinical trial of intraarticular steroid therapy. Following standardization of the clinical test procedures, 2 clinicians assessed 25 subjects independently at the same visit, and the same clinician assessed 88 subjects over an interval period of 2-10 weeks; in both cases prior to the steroid intervention. Clinical examination included assessment of bony enlargement, crepitus, quadriceps wasting, knee effusion, joint-line and anserine tenderness, and knee range of movement (ROM). Intraclass correlation coefficients (ICC), estimated kappa (κ), weighted kappa (κω), and Bland-Altman plots were used to determine interobserver and intraobserver levels of agreement. RESULTS: Using Landis and Koch criteria, interobserver κ scores were moderate for patellofemoral joint (κ = 0.53) and anserine tenderness (κ = 0.48); good for bony enlargement (κ = 0.66), quadriceps wasting (κ = 0.78), crepitus (κ = 0.78), medial tibiofemoral joint tenderness (κ = 0.76), and effusion assessed by ballottement (κ = 0.73) and bulge sign (κω = 0.78); and excellent for lateral tibiofemoral joint tenderness (κ = 1.00), flexion (ICC = 0.97), and extension (ICC = 0.87) ROM. Intraobserver κ scores were moderate for lateral tibiofemoral joint tenderness (κ = 0.60); good for crepitus (κ = 0.78), effusion assessed by ballottement test (κ = 0.77), patellofemoral joint (κ = 0.66), medial tibiofemoral joint (κ = 0.64), and anserine tenderness (κ = 0.73); and excellent for effusion assessed by bulge sign (κω = 0.83), bony enlargement (κ = 0.98), quadriceps wasting (κ = 0.83), flexion (ICC = 0.99), and extension (ICC = 0.96) ROM. CONCLUSION: Among individuals with symptomatic knee OA, the reliability of clinical examination of the knee was at least good for the majority of clinical signs of knee OA.
Authors: Jolanda Cibere; Nicholas Bellamy; Anona Thorne; John M Esdaile; Kelly J McGorm; Andrew Chalmers; Simon Huang; Paul Peloso; Kam Shojania; Joel Singer; Hubert Wong; Jacek Kopec Journal: Arthritis Rheum Date: 2004-02
Authors: G H Lo; T E McAlindon; J Niu; Y Zhang; C Beals; C Dabrowski; M P Hellio Le Graverand; D J Hunter Journal: Osteoarthritis Cartilage Date: 2009-06-26 Impact factor: 6.576
Authors: L Brosseau; S Balmer; M Tousignant; J P O'Sullivan; C Goudreault; M Goudreault; S Gringras Journal: Arch Phys Med Rehabil Date: 2001-03 Impact factor: 3.966
Authors: F W Roemer; A Guermazi; D J Hunter; J Niu; Y Zhang; M Englund; M K Javaid; J A Lynch; A Mohr; J Torner; C E Lewis; M C Nevitt; D T Felson Journal: Osteoarthritis Cartilage Date: 2008-10-17 Impact factor: 6.576
Authors: Terence W O'Neill; Matthew J Parkes; Nasimah Maricar; Elizabeth J Marjanovic; Richard Hodgson; Andrew D Gait; Timothy F Cootes; Charles E Hutchinson; David T Felson Journal: Ann Rheum Dis Date: 2015-06-26 Impact factor: 19.103
Authors: Marleen J de Leeuw; Alyt Oppewal; Roy G Elbers; Mireille W E J Knulst; Marco C van Maurik; Marjoleine C van Bruggen; Thessa I M Hilgenkamp; Patrick J E Bindels; Dederieke A M Maes-Festen Journal: BMJ Open Date: 2022-02-22 Impact factor: 2.692
Authors: Nuria E J Jansen; Dieuwke Schiphof; Edwin Oei; Judith Bosmans; Jolande van Teeffelen; Anita Feleus; Jos Runhaar; Joyce van Meurs; Sita M A Bierma-Zeinstra; Marienke van Middelkoop Journal: BMJ Open Date: 2022-03-04 Impact factor: 2.692
Authors: Camille Parsons; Nicholas R Fuggle; Mark H Edwards; Lyndsey Goulston; Anna E Litwic; Darshan Jagannath; Suzan van der Pas; Cyrus Cooper; Elaine M Dennison Journal: Aging Clin Exp Res Date: 2017-11-03 Impact factor: 3.636
Authors: Eleonor Svantesson; Eric Hamrin Senorski; Kate E Webster; Jón Karlsson; Theresa Diermeier; Benjamin B Rothrauff; Sean J Meredith; Thomas Rauer; James J Irrgang; Kurt P Spindler; C Benjamin Ma; Volker Musahl Journal: Knee Surg Sports Traumatol Arthrosc Date: 2020-08-06 Impact factor: 4.342